TILRAY INC

NASDAQ: TLRY (Tilray Brands, Inc.)

Last update: 22 Dec, 2024, 2:01PM

1.26

0.10 (8.62%)

Previous Close 1.16
Open 1.15
Volume 38,436,423
Avg. Volume (3M) 28,263,676
Market Cap 1,138,140,416
Price / Sales 1.32
Price / Book 0.350
52 Weeks Range
1.14 (-9%) — 2.97 (135%)
Earnings Date 9 Jan 2025
Profit Margin -26.18%
Operating Margin (TTM) -14.69%
Diluted EPS (TTM) -0.270
Quarterly Revenue Growth (YOY) 13.10%
Total Debt/Equity (MRQ) 11.15%
Current Ratio (MRQ) 2.47
Operating Cash Flow (TTM) -50.37 M
Levered Free Cash Flow (TTM) -35.79 M
Return on Assets (TTM) -1.40%
Return on Equity (TTM) -5.84%

Market Trend

Short Term Medium Term
Industry Drug Manufacturers - Specialty & Generic (US) Bearish Mixed
Drug Manufacturers - Specialty & Generic (Global) Mixed Mixed
Stock Tilray Brands, Inc. Bearish Bearish

AIStockmoo Score

0.5
Analyst Consensus -0.5
Insider Activity NA
Price Volatility 0.5
Technical Moving Averages 0.0
Technical Oscillators 2.0
Average 0.50

Similar Stocks

Stock Market Cap DY P/E (TTM) P/B
TLRY 1 B - - 0.350
INDV 2 B - - 145.25
ANIP 1 B - - 2.88
COLL 971 M - 12.86 4.15
IRWD 719 M - - 2.59
PCRX 658 M - 10.64 1.16

Tilray is a Canadian producer that cultivates and sells medical and recreational cannabis. In 2021, legacy Aphria acquired legacy Tilray in a reverse merger and renamed itself Tilray. The bulk of its sales are in Canada and in the international medical cannabis export market. US exposure consists of CBD products and alcohol.

Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
Investment Style Small Value
% Held by Insiders 0.67%
% Held by Institutions 12.10%
52 Weeks Range
1.14 (-9%) — 2.97 (135%)
Median 1.75 (38.89%)
Total 1 Hold
Firm Date Target Price Call Price @ Call
Roth MKM 11 Oct 2024 1.75 (38.89%) Hold 1.63

No data within this time range.

Date Type Details
02 Jan 2025 Announcement Tilray Brands Moves Earnings Date to January 10, 2025, in Observance of the National Day of Mourning
30 Dec 2024 Announcement New Year, New Chill: Explore the Latest Cannabis Beverages from Solei, Mollo, and XMG
19 Dec 2024 Announcement SweetWater Brewing Announces 28th Anniversary Bash With STS9 Headlining an Immersive Jamtronica Experience
19 Dec 2024 Announcement Tilray Brands, Inc. to Announce Second Quarter Fiscal Year 2025 Financial Results on January 9, 2025
18 Dec 2024 Announcement Redecan Cannabis Launches New Limited-Edition Genetics and Expands Signature 'Wrapped & Redee' Pre-roll Line for the Holidays
12 Dec 2024 Announcement Unwrap the Ultimate Holiday Experience with Good Supply’s Flavour-Packed Innovations
12 Dec 2024 Announcement Tilray Alternative Beverages Unveils HERB & BLOOM: A Cutting-Edge Era of Hemp-Derived Delta-9 THC Beverages
11 Dec 2024 Announcement Tilray Canada Launches THC Beverage Holiday Campaign Featuring XMG and Mollo Brands for Festive Season Celebrations
26 Nov 2024 Announcement The Broken Coast Difference: Tilray Brands’ Broken Coast Craft Cannabis Introduces New Premium Strain ‘Platinum Pavé’
21 Nov 2024 Announcement Redhook Brewery and Montlake Futures Team Up to Launch Montlake Gameday Gold Lager, a New Craft Beer in Support of University of Washington Athletes
21 Nov 2024 Announcement Tilray Brands Unveils 2024 Holiday Cannabis Gift Guide
21 Nov 2024 Announcement Tilray Brands Gets Festive with its 2024 Holiday Beverage Gift Guide
14 Nov 2024 Announcement Tilray Medical Launches its First Commercial “Grown in Germany” Medical Cannabis Products Under its Newly Expanded Cultivation License
14 Nov 2024 Announcement Tilray Medical Launches its First Commercial “Grown in Germany” Medical Cannabis Products Under its Newly Expanded Cultivation License
14 Nov 2024 Announcement Blue Point Brewery Expands Winter Seasonal Lineup with Blitz Beer American Lager and Hosts The Blue Point Blitz Celebration at Webster Hall
13 Nov 2024 Announcement Get Ready for Winter with 10 Barrel’s 13th Annual Pray for Snow Party
13 Nov 2024 Announcement Breckenridge Distillery's Latest Creation is the Perfect Addition to Your Holiday Bar: Breckenridge Candy Cane Vodka
07 Nov 2024 Announcement Tilray Medical Announces Positive Results from Study on Oral Cannabis Extract for Chemotherapy-Induced Emesis
31 Oct 2024 Announcement Breckenridge Brewery and University of Colorado Athletics Collaborate on New Limited-Edition Craft Beer
29 Oct 2024 Announcement Breckenridge Distillery and Flaviar Partner to Release Dad’s Stash Whiskey in Support of No-Shave November, Raising Funds for Fight Colorectal Cancer (Fight CRC)
22 Oct 2024 Announcement Blue Point Brewing Launches Big Mo Brew to Raise Funds and Awareness for Men’s Health During Movember
21 Oct 2024 Announcement Breckenridge Brewery Unveils Annual Release of Funslinger Lager in Collaboration with Colorado Artist Mike Graves
17 Oct 2024 Announcement Tilray Brands Celebrates Six Years of Cannabis Legalization in Canada with Industry-Leading Innovation in Brands and Products
16 Oct 2024 Announcement Tilray Announces Fall Craft Beer Lineup
10 Oct 2024 Announcement Dr. Manfred Ziegler Joins Flora Growth Corp. as Managing Director, Bolstering German Business with Unmatched Expertise
10 Oct 2024 Announcement Tilray Brands Reports Q1 2025 Financial Results
07 Oct 2024 Announcement Tilray Brands Launches Charlotte’s Web™ CBD Gummies in Canada
Show more

The support, resistance and trendline levels presented has been generated by an artificial intelligence (AI) model and should be interpreted with caution.

Portfolio

AI Template

Your price alert

Risk Profile

| | | | |
Conservative
Moderate Conservative
Moderate
Moderate Aggressive
Aggressive
Margin of Safety (EP)
Partial Profit (TP1)
Target Profit (TP2)
Maximum Loss (SL)

Disclaimer: The above is for illustrative purposes only and is NOT investment advice. Seek advice from a qualified financial professional.

Entry Price (EP)

Take Profit 1 (TP1)

Take Profit 2 (TP2)

Stop Loss (SL)

52W Range
 
52WL
 
52WH
SL
EP
TP1
TP2

All alert prices are within 52 weeks price range

Realized Profit -
Unrealized Profit -
Dividend Received 2025 -
Total Profit -
Avg. Return -
Quantity (Buy) -
Avg. Price (Buy) -
Quantity (Sold) -
Avg. Price (Sold) -
No stocks matching your criteria